Methanol Toxicity: Case Report
Methyl alcohol is an alcohol commonly used in the industry. It is also used in illegally produced drinks. Methyl alcohol poisoning is a clinical condition that causes vision loss, basal ganglion damage and metabolic acidosis with high risk of death. Bicarbonate supplementation, antidote administration and hemodialysis are applied to correct metabolic acidosis. We present in this study a 45-year-old male who was admitted to the Eye Polyclinic with sudden visual loss and was treated as methyl alcohol poisoning due to drinking 48 hours ago.
2. Ryu J, Lim KH, Ryu DR, Lee HW. Two cases of mehyl alcohol intoxication by sub-chronic inhalation and dermal exposure during aluminium CNC cutting in a small-sized subcontracted factory. Ann Occup Environ Med 2016 Nov 15; 28:65
3. Liesivuori J,Savolainen H. Methanol and formic acid toxicity- biochemical mechanisms. Pharmacol Toxicol 1991; 69:157-163.
4. Barceloux DG, Bond GR, Krenzelok EP, Cooper H,Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol 2002; 40:415-446
5. Sanaeı-Zadeh H, Zamani N, Shadnia S. Outcomes of visual disturbances after methanol poisoning. Clinical Toxicol 2011;49:102-107
6. Zakharov S, Pelclova D, Diblik P. Long-term visual damage after acute methanol poisonings: longitudinal cross-sectional study in 50 patients. Clin Toxicoll(Phila) 2015; 53: 884-892.
7 . Desai T, Sudhalkar A, Vyas U, Methanol poisoning: predictors of visual outcomes. JAMA Ophthalmol. 2013;131:358-364.
8. Hovda KE, Hunderi OH, Tajfjord A-B, Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs.. Journal of Internal Medicine 2005;258:181-190.
9. Paasma R, Hovda KE, Moghaddam HH. Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes-a multicenter study. Clinical Toxicology.
10. Bergeron R, Cardinal J, Geadah D. Prevention of methanol toxicity by ethanol theraphy. N Engl J Med 1982; 307:1528.
11. Burns MJ, Graudins A, Aaron CK, McMartin K, Brent J. Treatment of methanol poisoning with intravenous 4-methylpyrazole. Ann Emerg Med 1997; 30:829-832.
12. Zakharov S, Pelclova D, Navratil T, Belacek J. Fomepizole versus ethhanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak. Clin Toxicol (Phila) 2015; 53:797-806.
13. Omer Kurtas, Kemal Yavuz Imre, Erdal Ozer, Muhammet Can, Ismail Birincioglu, Celal Butun, Guven Seckin Kirci, Ali Yildirim, Samet Kiyak, Riza Yilmaz. The evaluation of deaths due to methyl alcohol intoxication. Biomedical Research 2017; 28 (8): 3680-3687.
14. Pınar YG. Tekirdağ ili Şarkoy ilçesinde şarap işletmeleri ile üzüm üreticilerinin çeşit seçimlerini etkileyen faktörlerin karşılaştırmalı analizi. (2008),Yüksek Lisans Tezi; Namık Kemal Üniversitesi Fen Bilimleri Enstitüsü, Tekirdağ.
15. Yaycı N, İnanıcı MA. Metil alkol (metanol) zehirlenmesi. Türkiye Klinikleri J Foren Med 2005;2(3):101-108.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Bulletin of Legal Medicine is an open access scientific journal. Open access means that all content is freely available without charge to the user or his/her institution on the principle that making research freely available to the public supports a greater global exchange of knowledge. The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
The Bulletin of Legal Medicine requires the author as the rights holder to sign and submit the journal's agreement form prior to acceptance. The authors retain copyright of their work and grant the Association for its publication. This ensures both that The Journal has the right to publish the article and that the author has confirmed various things including that it is their original work and that it is based on valid research.
Authors who publish with this journal agree to the following terms:
*Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
*Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
*Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.